₹408.45
₹-5.20 (-1.26%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹4,152 Cr
P/E
56.56
ROE
9.66%
ROCE
11.45%
About Gufic BioSciences Ltd
Gufic BioSciences principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Founded
1984
CEO
Jayesh P Choksi
Employees
2,926
HQ
Mumbai, India
About Gufic BioSciences Ltd
Gufic BioSciences principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Founded:1984
CEO:Jayesh P Choksi
Employees:2,926
HQ:Mumbai, India
Finished Products
1Sale of Products
₹2,194.96Cr2Other Operating Revenues
₹95.43Cr3Processing Charges
₹26.70CrRaw Materials
1Raw Material Consumed
₹978.47Cr2Purchases of Finished Goods
₹58.06Cr3Other Purchases
₹55.41Cr4Packing materials
₹36.36Cr5Purchases of Stock in Trade
₹25.84CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹448
52W Low
₹268
Volume44.95K
Avg VolumeN/A
Beta0.68
Dividend Yield0.02%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
56.56x
Valuation
P/B Ratio
6.24x
Valuation
EPS
₹7.32
Valuation
Dividend Yield
0.02%
Valuation
ROE
9.66%
Profitability
ROCE
11.45%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical and related productsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
79.8%
International
20.2%
India79.8%
Europe7.5%
Asia6.0%
Africa2.9%
South America2.4%
North America1.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.61x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.